Japan Excellent Inc
TSE:8987
Japan Excellent Inc
TSE:8987
Price:
148 000
JPY
-0.07%
Market Closed
Market Cap:
190.9B
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Japan Excellent Inc
148000
-100 (-0.07%)
| 52 Week Range |
113 700
153 300
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
Delete Alert
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Japan Excellent Inc
Japan Excellent Inc
| Current Assets | 17.4B |
| Cash & Short-Term Investments | 4.3B |
| Receivables | 417.1m |
| Other Current Assets | 12.7B |
| Non-Current Assets | 278.4B |
| Long-Term Investments | 254B |
| PP&E | 17.4B |
| Intangibles | 3.8B |
| Other Non-Current Assets | 3.2B |
| Current Liabilities | 31.3B |
| Accounts Payable | 1.1B |
| Accrued Liabilities | 224.2m |
| Short-Term Debt | 6.8B |
| Other Current Liabilities | 23.2B |
| Non-Current Liabilities | 118.6B |
| Long-Term Debt | 103.9B |
| Other Non-Current Liabilities | 14.6B |
Balance Sheet
Japan Excellent Inc
Japan Excellent Inc
Currency: JPY
| Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
2 441
|
1 280
|
3 028
|
2 290
|
2 940
|
3 597
|
4 708
|
5 591
|
2 207
|
3 791
|
7 487
|
8 224
|
7 166
|
19 651
|
7 458
|
6 392
|
10 467
|
12 835
|
|
| Cash Equivalents |
2 441
|
1 280
|
3 028
|
2 290
|
2 940
|
3 597
|
4 708
|
5 591
|
2 207
|
3 791
|
7 487
|
8 224
|
7 166
|
19 651
|
7 458
|
6 392
|
10 467
|
12 835
|
|
| Total Receivables |
1 215
|
371
|
467
|
433
|
682
|
651
|
834
|
891
|
795
|
559
|
456
|
392
|
380
|
326
|
310
|
423
|
356
|
432
|
|
| Accounts Receivables |
546
|
371
|
467
|
433
|
454
|
651
|
834
|
891
|
795
|
559
|
456
|
392
|
380
|
326
|
310
|
423
|
356
|
432
|
|
| Other Receivables |
669
|
0
|
0
|
0
|
228
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
12 274
|
13 050
|
11 832
|
10 997
|
11 886
|
11 890
|
13 364
|
14 730
|
15 927
|
16 547
|
16 296
|
16 242
|
16 955
|
16 581
|
15 370
|
11 846
|
11 974
|
12 700
|
|
| Total Current Assets |
15 930
|
14 700
|
15 327
|
13 721
|
15 509
|
16 137
|
18 906
|
21 213
|
18 930
|
20 898
|
24 239
|
24 858
|
24 501
|
36 558
|
23 138
|
18 662
|
22 797
|
25 967
|
|
| PP&E Net |
180 758
|
172 168
|
170 600
|
176 490
|
202 638
|
3 599
|
7 584
|
8 401
|
8 388
|
8 245
|
15 414
|
15 462
|
17 162
|
16 968
|
16 849
|
16 856
|
16 949
|
17 234
|
|
| PP&E Gross |
180 758
|
172 168
|
170 600
|
176 490
|
202 638
|
3 599
|
7 584
|
8 401
|
8 388
|
8 245
|
15 414
|
15 462
|
17 162
|
16 968
|
16 849
|
16 856
|
16 949
|
17 234
|
|
| Accumulated Depreciation |
2 200
|
4 042
|
6 023
|
8 009
|
10 120
|
740
|
920
|
1 140
|
1 379
|
1 625
|
1 880
|
2 158
|
2 468
|
2 732
|
3 079
|
3 432
|
3 711
|
4 034
|
|
| Intangible Assets |
8 566
|
8 566
|
8 566
|
8 566
|
8 566
|
8 566
|
8 565
|
9 107
|
9 107
|
9 108
|
9 108
|
9 108
|
9 117
|
9 114
|
9 172
|
9 192
|
9 188
|
3 778
|
|
| Long-Term Investments |
11
|
11
|
11
|
0
|
0
|
199 222
|
222 068
|
238 385
|
246 758
|
256 605
|
231 750
|
234 120
|
236 174
|
229 390
|
242 639
|
247 709
|
243 489
|
245 504
|
|
| Other Long-Term Assets |
221
|
486
|
536
|
411
|
537
|
497
|
778
|
931
|
1 262
|
1 225
|
1 686
|
1 852
|
1 837
|
1 975
|
2 162
|
2 121
|
2 401
|
2 856
|
|
| Total Assets |
205 486
N/A
|
195 930
-5%
|
195 040
0%
|
199 187
+2%
|
227 249
+14%
|
228 020
+0%
|
257 901
+13%
|
278 037
+8%
|
284 444
+2%
|
296 081
+4%
|
282 197
-5%
|
285 400
+1%
|
288 791
+1%
|
294 005
+2%
|
293 961
0%
|
294 540
+0%
|
294 824
+0%
|
295 338
+0%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
754
|
767
|
473
|
584
|
584
|
511
|
763
|
792
|
1 363
|
1 205
|
1 627
|
1 386
|
2 321
|
1 674
|
1 593
|
1 357
|
1 262
|
1 334
|
|
| Accrued Liabilities |
88
|
287
|
251
|
209
|
192
|
388
|
499
|
638
|
721
|
182
|
822
|
154
|
231
|
274
|
457
|
156
|
162
|
943
|
|
| Short-Term Debt |
49 000
|
12 000
|
12 000
|
4 900
|
9 000
|
500
|
0
|
0
|
1 000
|
1 000
|
900
|
2 000
|
9 000
|
0
|
0
|
3 000
|
5 000
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
13 000
|
13 000
|
34 500
|
14 000
|
15 000
|
27 500
|
20 540
|
21 760
|
24 000
|
24 750
|
9 750
|
10 600
|
13 510
|
13 750
|
19 770
|
17 770
|
22 510
|
|
| Other Current Liabilities |
308
|
406
|
456
|
433
|
383
|
406
|
475
|
432
|
526
|
511
|
526
|
518
|
607
|
640
|
503
|
485
|
568
|
507
|
|
| Total Current Liabilities |
50 150
|
26 460
|
26 179
|
40 626
|
24 159
|
16 804
|
29 237
|
22 402
|
25 370
|
26 898
|
28 625
|
13 807
|
22 759
|
16 099
|
16 303
|
24 768
|
24 761
|
25 294
|
|
| Long-Term Debt |
65 833
|
79 252
|
79 332
|
69 288
|
98 752
|
97 800
|
97 900
|
113 360
|
109 140
|
112 900
|
96 850
|
114 850
|
110 000
|
112 090
|
111 850
|
105 830
|
105 830
|
107 090
|
|
| Other Liabilities |
211
|
199
|
78
|
0
|
0
|
8 870
|
10 051
|
11 247
|
12 076
|
12 642
|
12 789
|
13 016
|
13 654
|
13 397
|
13 601
|
13 724
|
13 574
|
13 879
|
|
| Total Liabilities |
116 194
N/A
|
105 911
-9%
|
105 590
0%
|
109 914
+4%
|
122 910
+12%
|
123 475
+0%
|
137 188
+11%
|
147 009
+7%
|
146 587
0%
|
152 441
+4%
|
138 264
-9%
|
141 673
+2%
|
146 414
+3%
|
141 586
-3%
|
141 754
+0%
|
144 322
+2%
|
144 165
0%
|
146 263
+1%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
87 083
|
87 083
|
87 083
|
87 083
|
102 052
|
102 052
|
117 901
|
127 951
|
134 435
|
139 973
|
139 973
|
139 973
|
139 973
|
147 908
|
147 908
|
145 908
|
145 908
|
143 908
|
|
| Retained Earnings |
2 210
|
2 936
|
2 368
|
2 190
|
2 286
|
2 493
|
2 812
|
3 078
|
3 422
|
3 667
|
3 961
|
3 754
|
2 404
|
4 511
|
4 299
|
4 311
|
4 751
|
5 167
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
89 293
N/A
|
90 019
+1%
|
89 451
-1%
|
89 273
0%
|
104 339
+17%
|
104 545
+0%
|
120 713
+15%
|
131 029
+9%
|
137 857
+5%
|
143 640
+4%
|
143 934
+0%
|
143 727
0%
|
142 377
-1%
|
152 419
+7%
|
152 206
0%
|
150 218
-1%
|
150 659
+0%
|
149 075
-1%
|
|
| Total Liabilities & Equity |
205 486
N/A
|
195 930
-5%
|
195 040
0%
|
199 187
+2%
|
227 249
+14%
|
228 020
+0%
|
257 901
+13%
|
278 037
+8%
|
284 444
+2%
|
296 081
+4%
|
282 197
-5%
|
285 400
+1%
|
288 791
+1%
|
294 005
+2%
|
293 961
0%
|
294 540
+0%
|
294 824
+0%
|
295 338
+0%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Switch to:
Switch to:
See Also
Discover More
